Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

NextPoint Therapeutics, Inc.

Clinical trials sponsored by NextPoint Therapeutics, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New antibody drug aims to turn immune cells against cancer Results expected Apr 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New antibody drug aims to turn immune cells against cancer

Disease control Recruiting now

This early-stage study tests a new drug called NPX372 in people with advanced solid tumors that have not responded to standard treatments. The drug is designed to help the body's immune cells recognize and attack cancer cells. The main goals are to check the drug's safety and fin…

Phase 1 • Sponsor: NextPoint Therapeutics, Inc. • Aim: Disease control

Last updated Sep 10, 2026 00:00 UTC